#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-renal cell carcinoma of kidney Neurofibromatosis Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Human papilloma virus immunisation Medulloblastoma Pulmonary arterial hypertension Atopic keratoconjunctivitis Anaplastic large cell lymphoma T- and null-cell types Bronchiectasis Acute myeloid leukaemia refractory Pelizaeus-Merzbacher disease Laryngeal squamous cell carcinoma Infertility female Metastatic malignant melanoma Colorectal cancer metastatic More trials…

    Learn about Rare Diseases

    Andersen-Tawil syndrome – Life with Disease Chondrosarcoma Myelodysplastic syndrome with excess blasts – Trials in Disease Hereditary hypophosphataemic rickets – Life with Disease Acute respiratory distress syndrome Phenylketonuria – Treatment Undifferentiated sarcoma – Diagnostics Haemolytic uraemic syndrome Alagille syndrome – Diagnostics Biotinidase deficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Arginine Hydrochloride Azd5863 Trehalose Dihydrate (Ph.eur.) Lisinopril Dihydrate Fingolimod Hydrochloride Mepolizumab Vericiguat Dexamethasone Ph. Eur. [18F]-Altanserin Linvoseltamab Tianeptine Indacaterol Maleate Erlotinib Namilumab 4-Hydroxy-N-Desmethyltamoxifen Piperacillin Monohydrate Pritelivir PALAZESTRANT Gallium (68Ga) Chloride Donidalorsen More therapies…

    Learn about Your Condition

    Vomiting Notalgia paraesthetica Primary hypogonadism Hydrocele Neurogenic bladder Chronic hepatic failure Cervix carcinoma stage III Meningorrhagia Kawasaki's disease Dementia Progressive multiple sclerosis Synovial sarcoma metastatic Hypersensitivity Hand fracture Lower limb fracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness of Lutetium (177Lu) Edotreotide for Patients with Neuroendocrine Tumors and Other SSTR-Positive Tumors

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    • Paraganglion neoplasm
    • Phaeochromocytoma
    Investigated Drugs:
    • Lutetium (177Lu) Edotreotide
    Italy

  • Study on the Effectiveness of Dexamethasone for Reducing Swelling, Pain, and Jaw Stiffness in Patients Undergoing Wisdom Tooth Extraction

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone
    Spain

  • Study on the Effectiveness and Safety of Masitinib with Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Masitinib
    Denmark France Greece Norway Sweden

  • Study on Filgotinib and Triamcinolone for Newly Diagnosed Rheumatoid Arthritis Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Filgotinib
    • Triamcinolone Acetonide
    The Netherlands

  • Study of Pembrolizumab and Enfortumab Vedotin for Patients with Collecting Duct and Renal Medullary Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-renal cell carcinoma of kidney
    • Renal cell carcinoma
    Investigated Drugs:
    • Pembrolizumab
    Italy

  • Study on Avelumab for Patients with Advanced Urothelial Cancer After Initial Chemotherapy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    • Bladder cancer
    Investigated Drugs:
    • Avelumab
    The Netherlands
Previous Page
1 … 807 808 809 810 811 … 1,659
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!